Global Nuclear Molecular Imaging System Market Research Report 2025

Publication ID:

PB502254561

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Nuclear Molecular Imaging System was valued at US$ 2551 million in the year 2024 and is projected to reach a revised size of US$ 4096 million by 2031, growing at a CAGR of 7.1% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Molecular Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Molecular Imaging System.
The Nuclear Molecular Imaging System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Molecular Imaging System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Molecular Imaging System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bruker
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Digirad Corporation
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
Mediso Medical Imaging Systems, Ltd.
SurgicEye GmbH
CMR Naviscan Corporation
Segment by Type
Positron Emission Tomography
Single-photon Emission Computed Tomography
Planar Scintigraphy Systems
Segment by Application
Oncology
Cardiology
Neurology
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Molecular Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Molecular Imaging System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nuclear Molecular Imaging System Market Overview
1.1 Product Definition
1.2 Nuclear Molecular Imaging System by Type
1.2.1 Global Nuclear Molecular Imaging System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Positron Emission Tomography
1.2.3 Single-photon Emission Computed Tomography
1.2.4 Planar Scintigraphy Systems
1.3 Nuclear Molecular Imaging System by Application
1.3.1 Global Nuclear Molecular Imaging System Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Global Nuclear Molecular Imaging System Market Size Estimates and Forecasts
1.4.1 Global Nuclear Molecular Imaging System Revenue 2020-2031
1.4.2 Global Nuclear Molecular Imaging System Sales 2020-2031
1.4.3 Global Nuclear Molecular Imaging System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nuclear Molecular Imaging System Market Competition by Manufacturers
2.1 Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nuclear Molecular Imaging System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nuclear Molecular Imaging System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Molecular Imaging System, Product Type & Application
2.7 Global Key Manufacturers of Nuclear Molecular Imaging System, Date of Enter into This Industry
2.8 Global Nuclear Molecular Imaging System Market Competitive Situation and Trends
2.8.1 Global Nuclear Molecular Imaging System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nuclear Molecular Imaging System Players Market Share by Revenue
2.8.3 Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Molecular Imaging System Market Scenario by Region
3.1 Global Nuclear Molecular Imaging System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nuclear Molecular Imaging System Sales by Region: 2020-2031
3.2.1 Global Nuclear Molecular Imaging System Sales by Region: 2020-2025
3.2.2 Global Nuclear Molecular Imaging System Sales by Region: 2026-2031
3.3 Global Nuclear Molecular Imaging System Revenue by Region: 2020-2031
3.3.1 Global Nuclear Molecular Imaging System Revenue by Region: 2020-2025
3.3.2 Global Nuclear Molecular Imaging System Revenue by Region: 2026-2031
3.4 North America Nuclear Molecular Imaging System Market Facts & Figures by Country
3.4.1 North America Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.4.3 North America Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Molecular Imaging System Market Facts & Figures by Country
3.5.1 Europe Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.5.3 Europe Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Molecular Imaging System Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Molecular Imaging System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nuclear Molecular Imaging System Sales by Region (2020-2031)
3.6.3 Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nuclear Molecular Imaging System Market Facts & Figures by Country
3.7.1 Latin America Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.7.3 Latin America Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Molecular Imaging System Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Molecular Imaging System Sales by Type (2020-2031)
4.1.1 Global Nuclear Molecular Imaging System Sales by Type (2020-2025)
4.1.2 Global Nuclear Molecular Imaging System Sales by Type (2026-2031)
4.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Type (2020-2031)
4.2 Global Nuclear Molecular Imaging System Revenue by Type (2020-2031)
4.2.1 Global Nuclear Molecular Imaging System Revenue by Type (2020-2025)
4.2.2 Global Nuclear Molecular Imaging System Revenue by Type (2026-2031)
4.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Type (2020-2031)
4.3 Global Nuclear Molecular Imaging System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nuclear Molecular Imaging System Sales by Application (2020-2031)
5.1.1 Global Nuclear Molecular Imaging System Sales by Application (2020-2025)
5.1.2 Global Nuclear Molecular Imaging System Sales by Application (2026-2031)
5.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Application (2020-2031)
5.2 Global Nuclear Molecular Imaging System Revenue by Application (2020-2031)
5.2.1 Global Nuclear Molecular Imaging System Revenue by Application (2020-2025)
5.2.2 Global Nuclear Molecular Imaging System Revenue by Application (2026-2031)
5.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Application (2020-2031)
5.3 Global Nuclear Molecular Imaging System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bruker
6.1.1 Bruker Company Information
6.1.2 Bruker Description and Business Overview
6.1.3 Bruker Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bruker Nuclear Molecular Imaging System Product Portfolio
6.1.5 Bruker Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare Nuclear Molecular Imaging System Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Siemens Healthcare
6.3.1 Siemens Healthcare Company Information
6.3.2 Siemens Healthcare Description and Business Overview
6.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Siemens Healthcare Nuclear Molecular Imaging System Product Portfolio
6.3.5 Siemens Healthcare Recent Developments/Updates
6.4 Philips Healthcare
6.4.1 Philips Healthcare Company Information
6.4.2 Philips Healthcare Description and Business Overview
6.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Philips Healthcare Nuclear Molecular Imaging System Product Portfolio
6.4.5 Philips Healthcare Recent Developments/Updates
6.5 Canon Medical Systems
6.5.1 Canon Medical Systems Company Information
6.5.2 Canon Medical Systems Description and Business Overview
6.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Canon Medical Systems Nuclear Molecular Imaging System Product Portfolio
6.5.5 Canon Medical Systems Recent Developments/Updates
6.6 Hitachi Medical
6.6.1 Hitachi Medical Company Information
6.6.2 Hitachi Medical Description and Business Overview
6.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hitachi Medical Nuclear Molecular Imaging System Product Portfolio
6.6.5 Hitachi Medical Recent Developments/Updates
6.7 Digirad Corporation
6.7.1 Digirad Corporation Company Information
6.7.2 Digirad Corporation Description and Business Overview
6.7.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Digirad Corporation Nuclear Molecular Imaging System Product Portfolio
6.7.5 Digirad Corporation Recent Developments/Updates
6.8 DDD-Diagnostics A/S
6.8.1 DDD-Diagnostics A/S Company Information
6.8.2 DDD-Diagnostics A/S Description and Business Overview
6.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Portfolio
6.8.5 DDD-Diagnostics A/S Recent Developments/Updates
6.9 Neusoft Medical Systems Co. Ltd.
6.9.1 Neusoft Medical Systems Co. Ltd. Company Information
6.9.2 Neusoft Medical Systems Co. Ltd. Description and Business Overview
6.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Portfolio
6.9.5 Neusoft Medical Systems Co. Ltd. Recent Developments/Updates
6.10 Mediso Medical Imaging Systems, Ltd.
6.10.1 Mediso Medical Imaging Systems, Ltd. Company Information
6.10.2 Mediso Medical Imaging Systems, Ltd. Description and Business Overview
6.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Portfolio
6.10.5 Mediso Medical Imaging Systems, Ltd. Recent Developments/Updates
6.11 SurgicEye GmbH
6.11.1 SurgicEye GmbH Company Information
6.11.2 SurgicEye GmbH Description and Business Overview
6.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SurgicEye GmbH Nuclear Molecular Imaging System Product Portfolio
6.11.5 SurgicEye GmbH Recent Developments/Updates
6.12 CMR Naviscan Corporation
6.12.1 CMR Naviscan Corporation Company Information
6.12.2 CMR Naviscan Corporation Description and Business Overview
6.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Portfolio
6.12.5 CMR Naviscan Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Molecular Imaging System Industry Chain Analysis
7.2 Nuclear Molecular Imaging System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Molecular Imaging System Production Mode & Process Analysis
7.4 Nuclear Molecular Imaging System Sales and Marketing
7.4.1 Nuclear Molecular Imaging System Sales Channels
7.4.2 Nuclear Molecular Imaging System Distributors
7.5 Nuclear Molecular Imaging System Customer Analysis
8 Nuclear Molecular Imaging System Market Dynamics
8.1 Nuclear Molecular Imaging System Industry Trends
8.2 Nuclear Molecular Imaging System Market Drivers
8.3 Nuclear Molecular Imaging System Market Challenges
8.4 Nuclear Molecular Imaging System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bruker
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Digirad Corporation
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
Mediso Medical Imaging Systems, Ltd.
SurgicEye GmbH
CMR Naviscan Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂